PRASAD SUYASH 4
4 · Taysha Gene Therapies, Inc. · Filed Sep 25, 2020
Insider Transaction Report
Form 4
PRASAD SUYASH
CMO and Head of R&D
Transactions
- Award
Common Stock
2020-09-23+668,745→ 668,745 total
Footnotes (2)
- [F1]The shares underlying the RSU vest in 4 equal annual installments on each of June 29, 2021, June 29, 2022, June 29, 2023 and June 29, 2024, subject to the Reporting Person's continuous service as of each such vesting date
- [F2]Each RSU represents a contingent right to receive one share the Issuer's common stock.